Cambridge, United Kingdom

Alan Norman Howard

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Nutraceutical Formulations. Top assignees: The Howard Foundation, Howard Foundation Holdings Limited, The Original Creatine Patent Company. Active years: 1980-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Norman Howard. Retrieved from https://idiyas.com/inventor/alan-norman-howard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 87.5


 

Average Co-Inventor Count = 1.8

ph-index = 13

Forward Citations = 439(Granted Patents)


Location History:

  • Trumpington, Cambridge CB2 2HQ, GB (1985 - 1990)
  • Cambridge, GB (1980 - 2003)
  • Great Shelford, GB (1999 - 2017)
  • Cambridgeshire, GB (2020)

Company Filing History:


Years Active: 1980-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Neurodegenerative Disease
Visual Performance
Food Supplements
Creatine
Flavonols
Polyphenols
Mesozeaxanthin
Carotenoids
Cereal Snackfoods
Culinary Seasoning
Confectionary Products
Obesity Treatment
24 patents (USPTO):Explore Patents

Title: Alan Norman Howard: Innovator in Neurodegenerative Disease Research

Introduction

Alan Norman Howard, based in Cambridge, GB, is a prominent inventor with an impressive portfolio of 22 patents. His innovative contributions primarily focus on advancements in the prevention and treatment of neurodegenerative diseases, showcasing a commitment to improving human health through scientific discovery.

Latest Patents

Among Howard's latest patents is a method for the prevention and treatment of dementia in human subjects. This innovative approach involves administering an effective amount of a composition that includes carotenoids such as lutein, zeaxanthin, and meso-zeaxanthin, along with omega-3 fatty acids. Additionally, he has developed a composition comprising meso-zeaxanthin (MZ) intended for use as a dietary supplement or food additive to enhance visual performance and support macular pigmentation.

Career Highlights

Throughout his career, Alan Norman Howard has played a significant role in companies such as the Howard Foundation and Howard Foundation Holdings Limited. His work has had a lasting impact on the field of neurodegenerative diseases and visual health, reflecting his dedication to advancing medical research and practical applications.

Collaborations

Howard has collaborated with esteemed professionals in his field, including Roger Charles Harris and John Nolan. These partnerships have enriched his research endeavors, fostering innovation and contributing to the development of groundbreaking solutions in healthcare.

Conclusion

Alan Norman Howard's contributions to medical science and innovation underscore his position as a leading inventor in neurodegenerative disease research. His patents exemplify a forward-thinking approach to health and wellness, promising to enhance the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…